Literature DB >> 23712106

Validation of the Amsterdam IADL Questionnaire©, a new tool to measure instrumental activities of daily living in dementia.

Sietske A M Sikkes1, Dirk L Knol, Yolande A L Pijnenburg, Elly S M de Lange-de Klerk, Bernard M J Uitdehaag, Philip Scheltens.   

Abstract

BACKGROUND: This study describes the validation of a new instrument measuring instrumental activities of daily living (IADL), the Amsterdam IADL Questionnaire© (a registered copyright of the Alzheimer Center of the VU University Medical Center). This informant-based tool aimed at detecting IADL problems in incipient dementia was previously found to have a high internal consistency and test-retest reliability.
METHODS: Patients and their informants who visited the Alzheimer Center of the VU University Medical Center were included in this study. Item response theory was used to estimate the individuals' trait levels as a measure of IADL disability. Construct validity was tested by correlating estimated trait levels with clinical and demographic measures using Pearson's or Kendall's τ correlation coefficients. Additionally, estimated trait levels between patients with and without dementia and between patients with early- and late-onset dementia were compared using independent t tests.
RESULTS: A total of 206 informants of patients completed the Amsterdam IADL Questionnaire. The correlations between estimated trait levels and other measures were in concordance with previously formed hypotheses. Patients diagnosed with dementia (n = 93) had higher estimated trait levels than patients without dementia (n = 96), Cohen's effect size, d = 1.04, t(187) = 7.1, p < 0.001. We found no differences between early- and late-onset dementia patients.
CONCLUSIONS: Results suggest that the Amsterdam IADL Questionnaire is a reliable and valid instrument in the evaluation of dementia.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23712106     DOI: 10.1159/000346277

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  27 in total

Review 1.  Conceptualizing and Assessing Everyday Functioning in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  Victoria M Kordovski; Savanna M Tierney; Steven Paul Woods
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 2.  Amsterdam Dementia Cohort: Performing Research to Optimize Care.

Authors:  Wiesje M van der Flier; Philip Scheltens
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire.

Authors:  Roos J Jutten; Carel F W Peeters; Sophie M J Leijdesdorff; Pieter Jelle Visser; Andrea B Maier; Caroline B Terwee; Philip Scheltens; Sietske A M Sikkes
Journal:  Alzheimers Dement (Amst)       Date:  2017-03-31

4.  Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: a pilot study.

Authors:  Q Oort; L Dirven; W Meijer; S A M Sikkes; B M J Uitdehaag; J C Reijneveld; M J B Taphoorn
Journal:  J Neurooncol       Date:  2017-02-01       Impact factor: 4.130

5.  A novel cognitive-functional composite measure to detect changes in early Alzheimer's disease: Test-retest reliability and feasibility.

Authors:  Roos J Jutten; John Harrison; Philippe R Lee Meeuw Kjoe; Esther M Opmeer; Niki S M Schoonenboom; Frank Jan de Jong; Craig W Ritchie; Philip Scheltens; Sietske A M Sikkes
Journal:  Alzheimers Dement (Amst)       Date:  2017-12-27

6.  A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition study.

Authors:  Roos J Jutten; John Harrison; Frank Jan de Jong; André Aleman; Craig W Ritchie; Philip Scheltens; Sietske A M Sikkes
Journal:  Alzheimers Dement (N Y)       Date:  2017-02-09

7.  Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study.

Authors:  Nienke Legdeur; Maryam Badissi; Stephen F Carter; Sophie de Crom; Aleid van de Kreeke; Ralph Vreeswijk; Marijke C Trappenburg; Mardien L Oudega; Huiberdina L Koek; Jos P van Campen; Carolina J P W Keijsers; Chinenye Amadi; Rainer Hinz; Mark F Gordon; Gerald Novak; Jana Podhorna; Erik Serné; Frank Verbraak; Maqsood Yaqub; Arjan Hillebrand; Alessandra Griffa; Neil Pendleton; Sophia E Kramer; Charlotte E Teunissen; Adriaan Lammertsma; Frederik Barkhof; Bart N M van Berckel; Philip Scheltens; Majon Muller; Andrea B Maier; Karl Herholz; Pieter Jelle Visser
Journal:  BMC Geriatr       Date:  2018-11-26       Impact factor: 3.921

8.  Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer's disease: a randomized, placebo-controlled trial.

Authors:  Martin Bystad; Ole Grønli; Ingrid Daae Rasmussen; Nina Gundersen; Lene Nordvang; Henrik Wang-Iversen; Per M Aslaksen
Journal:  Alzheimers Res Ther       Date:  2016-03-23       Impact factor: 6.982

9.  The EMIF-AD PreclinAD study: study design and baseline cohort overview.

Authors:  Elles Konijnenberg; Stephen F Carter; Mara Ten Kate; Anouk den Braber; Jori Tomassen; Chinenye Amadi; Linda Wesselman; Hoang-Ton Nguyen; Jacoba A van de Kreeke; Maqsood Yaqub; Matteo Demuru; Sandra D Mulder; Arjan Hillebrand; Femke H Bouwman; Charlotte E Teunissen; Erik H Serné; Annette C Moll; Frank D Verbraak; Rainer Hinz; Neil Pendleton; Adriaan A Lammertsma; Bart N M van Berckel; Frederik Barkhof; Dorret I Boomsma; Philip Scheltens; Karl Herholz; Pieter Jelle Visser
Journal:  Alzheimers Res Ther       Date:  2018-08-04       Impact factor: 6.982

10.  Thinking-While-Moving Exercises May Improve Cognition in Elderly with Mild Cognitive Deficits: A Proof-of-Principle Study.

Authors:  Casper de Boer; Holly V Echlin; Alica Rogojin; Bianca R Baltaretu; Lauren E Sergio
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2018-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.